Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Observational study to evaluate therapeutic switch to a NNRTI-based regimen on quality of life of HIV-positive patients

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Reverse Transcriptase Inhibitors

Criteria

Inclusion Criteria:

• NNRTI-naive patients with positive HIV serology, treated with at least triple combination therapy, with a viral load < 500 copies/ml, in whom a new treatment comprising an NNRTI is initiated for a reason other than inefficacy of treatment will be included

• Patients must read and write French

Exclusion Criteria:

• Patients in whom a new treatment is initiated because of treatment failure

• new treatment does not comprise an NNRTI